3Billion Inc is a Korea-based company principally engaged in the provision of genetic testing services. The Company is principally engaged in the provision of rare genetic disease diagnostic testing services. The Company is also engaged in the research and development of technology that automatically reads the pathogenicity of numerous genetic variants found in the genome.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
16/07/26	₩5,900.00	+4.24%	229,768
15/07/26	₩5,660.00	+4.24%	108,227
14/07/26	₩5,430.00	-3.72%	424,867
13/07/26	₩5,640.00	-4.41%	109,518
10/07/26	₩5,900.00	+8.46%	249,655

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

End-of-day quote Korea S.E. Other stock markets 16/07/2026			5-day change	1st Jan Change
5,900.00 ^KRW	+4.24%		0.00%	-67.64%

06-01	3billion Launches 3B-NEO, Genomic Newborn Screening Service Covering 595 Clinically Actionable Genetic Conditions	CI
05-13	3billion, Inc. announced that it has received KRW 29.999999888 billion in funding from Meritz Securities Co., Ltd., Wonik Investment Partners Co., Ltd.	CI

Market Cap	188B 126M 110M 102M 93.85M 177M 12.16B 181M 1.22B 479M 5.96B 474M 464M 20.5B	P/E 2025	-107x	P/E 2026 *	-
Enterprise Value	171M 115K 100K 92.65K 85.4K 161K 11.06M 165K 1.11M 436K 5.42M 431K 422K 18.66M	EV / Sales 2025	49x	EV / Sales 2026 *	-
Free-Float	75.48%	Yield 2025 *	-	Yield 2026 *	-

06-01	3billion Launches 3B-NEO, Genomic Newborn Screening Service Covering 595 Clinically Actionable Genetic Conditions	CI
05-13	3billion, Inc. announced that it has received KRW 29.999999888 billion in funding from Meritz Securities Co., Ltd., Wonik Investment Partners Co., Ltd.	CI
04-23	3billion, Inc. announced that it expects to receive KRW 29.999999888 billion in funding from Meritz Securities Co., Ltd., Wonik Investment Partners Co., Ltd. and other investors.	CI
04-09	3Billion Inc wins 955 million won order	RE
03-23	3billion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
18/03/25	3Billion Inc Wins 655 Million Won Order	RE

1 day	+4.24%
Current month	-2.48%
1 month	-15.95%
3 months	-53.69%
6 months	-62.32%
Current year	-67.64%

3billion, Inc. Stock

Stocks

A394800

KR7394800007

Biotechnology & Medical Research

Valuation: 3billion, Inc.

Chart: 3billion, Inc.

Latest news : 3billion, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: 3billion, Inc.

Latest insider transactions

Bio Diagnostics & Testing

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

1 week	5,310	6,230
1 month	5,310	6,780
Current year	5,310	18,690
1 year	5,310	20,100
3 years	3,025	20,100
5 years	3,025	20,100
10 years	3,025	20,100

Manager	Title	Age	Since
Chang-Won Geum CEO	Chief Executive Officer	45	10/10/2016
Soon-Il Park DFI	Director of Finance/CFO	46	01/10/2020
Ki-Hyeon Kang COO	Chief Operating Officer	44	01/02/2019

Director	Title	Age	Since
Woo-Kyum Kim BRD	Director/Board Member	52	20/03/2020
Chang-Won Geum BRD	Director/Board Member	45	10/10/2016
Se-Hwan Kim BRD	Director/Board Member	44	10/10/2016

Date	Insider	Type	Main position	Quantity	% Market Cap.
16/04/25	Soon-Il Park	Others	Chief Financial Officer	44,000	0.1387%
07/03/25	Hae-In Lee	Fiscal year	Executive/Senior Manager	18,000	0.0568%
07/03/25	Ki-hyun Kang	Fiscal year		10,000	0.0316%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
3BILLION, INC.	+4.24%	0.00%	-18.40%	-	126M
VERACYTE, INC.	-0.15%	+3.79%	+151.51%	+98.56%	4.72B
ADAPTIVE BIOTECHNOLOGIES CORPORATION	+3.71%	+8.83%	+120.60%	+201.98%	3.67B
IOVANCE BIOTHERAPEUTICS, INC.	+7.30%	+18.20%	+124.22%	-38.65%	2.23B
CAREDX, INC.	-1.51%	+39.35%	+233.45%	+285.35%	2.05B
BGI GENOMICS CO., LTD.	-5.50%	-0.75%	-29.67%	-37.76%	2.04B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+2.12%	+18.88%	+197.94%	-41.99%	1.07B
SEEGENE, INC.	-2.39%	-1.55%	-10.78%	+35.95%	875M
HANGZHOU ALLTEST BIOTECH CO., LTD.	-4.16%	+6.17%	-34.21%	-11.74%	513M
CURIOX BIOSYSTEMS CO., LTD	-3.06%	-3.18%	-3.97%	-	476M
Average	+0.06%	+9.12%	+73.07%	+61.46%	1.78B
Weighted average by Cap.	+0.68%	+10.68%	+114.47%	+93.76%

	2025	2026 *
Net sales	10.8B 7.26M 6.35M 5.86M 5.4M 10.18M 699M 10.4M 70M 27.53M 343M 27.28M 26.68M 1.18B	-
Net income	-5.8B -3.9M -3.41M -3.15M -2.9M -5.46M -376M -5.59M -37.6M -14.79M -184M -14.65M -14.33M -633M	-
Net Debt	-16.9B -11.37M -9.93M -9.16M -8.45M -15.92M -1.09B -16.28M -110M -43.09M -536M -42.68M -41.75M -1.85B	-